作者:Soni Yadav、Deepa Sinha、Sanjay K. Singh、Vinay K. Singh
DOI:10.1111/j.1747-0285.2012.01407.x
日期:2012.10
A series of new benzimidazole congeners were synthesized, and their structures were elucidated on the basis of elemental analyses and spectral studies (1H NMR, FT‐IR and EI‐MS). Preliminary pharmacokinetic studies showed a promising outlook for further in vivo evaluation. The newly synthesized compounds were tested in vitro on human breast carcinoma cell line (MCF‐7) in which EGFR is highly expressed. Most of the tested compounds exhibited antitumor activity with IC50 values in the micro to nano molar range.